Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Lupin Limited
LUPINLupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women's health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India. Address: Kalpataru Inspire, Mumbai, India, 400055
Analytics
WallStreetin tavoitehinta
129 740.57 INRP/E-suhde
45.6586Osinkotuotto
0.35 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut LUPIN
Osinkoanalytiikka LUPIN
Osinkojen kasvu 5 vuoden aikana
-20 %Jatkuva kasvu
1 vuosiMaksusuhde 5 vuoden keskiarvo
-2 %Osinkohistoria LUPIN
Osakkeen arvostus LUPIN
Talousasiat LUPIN
Tuloksia | 2019 | Dynamiikka |